We are interested in the understanding protein-ligand interactions and the microevolutionary processes that permit and promote changes at the protein-ligand interface. To explore these issues, we are studying the Phd repressor/antitoxin and selected homologs. Phd is a small 73 amino acid protein with multiple macromolecular ligands. Phd dimerizes, binds to operator DNA, binds to the Doc toxin, and engages in an additional contact with Doc that mediates the cooperative interactions between adjacent Phd dimers and thus enhance repression. All four of these protein-ligand interactions contribute to the specificity and affinity of the repressive complex.
The specific aims of the current proposals are: 1) To determine how the spacing and sequence of the palindromic sites in the operator affects the formation of the repressive complex. 2) To develop quantitative in vitro assays for all four interactions. 3) To determine the role of the two structurally identified Phd-Doc interactions on a) toxicity, b) neutralization of the toxin and c) corepression. The long-term objective of this research is to understand protein-ligand interactions well enough to recognize ligand binding domains, match proteins to their preferred ligands, design proteins to bind specific ligands and design ligands to bind specific proteins. A superior understanding of protein-ligand interactions will assist in the rational design of drugs (ligands) that interact with specific protein targets (agents of disease).

Public Health Relevance

The proposed research will contribute to the understanding of protein-ligand interactions and a superior understanding of protein-ligand interactions will enable us to design ligands (drugs) that bind specific proteins (viral or microbial or human) that produce human disease. The proposed research will also contribute to the understanding of plasmid addiction elements. These self-selecting sib-killing plasmid addiction elements may have diverse applications in the attenuation of bacteria for vaccine production, in enhancing and prolonging the action of antibiotics and in the modification or elimination of plasmid-borne virulence determinants.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
2R15GM067668-04
Application #
7646090
Study Section
Prokaryotic Cell and Molecular Biology Study Section (PCMB)
Program Officer
Basavappa, Ravi
Project Start
2003-04-01
Project End
2012-08-31
Budget Start
2009-09-30
Budget End
2012-08-31
Support Year
4
Fiscal Year
2009
Total Cost
$220,900
Indirect Cost
Name
University of Alabama in Huntsville
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
949687123
City
Huntsville
State
AL
Country
United States
Zip Code
35899
Garcia-Pino, Abel; Balasubramanian, Sreeram; Wyns, Lode et al. (2010) Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity. Cell 142:101-11
Garcia-Pino, Abel; Christensen-Dalsgaard, Mikkel; Wyns, Lode et al. (2008) Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation. J Biol Chem 283:30821-7
McKinley, James Estle; Magnuson, Roy David (2005) Characterization of the Phd repressor-antitoxin boundary. J Bacteriol 187:765-70
Zhao, Xueyan; Magnuson, Roy David (2005) Percolation of the phd repressor-operator interface. J Bacteriol 187:1901-12
Smith, Jeremy Allen; Magnuson, Roy David (2004) Modular organization of the Phd repressor/antitoxin protein. J Bacteriol 186:2692-8